跳至主要内容
临床试验/NCT04355624
NCT04355624已完成不适用

Characterization of Kidney Involvement in COVID-19 Disease: a French Multi-center Prospective Observational Study

Centre Hospitalier Universitaire de Nice4 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2020年4月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
45
试验地点
4
主要终点
Kidney involvement in COVID-19 disease

研究概览

简要总结

Novel coronavirus disease (COVID-19) is a newly discovered contagious disease caused by SARS-CoV-2 virus, primarily manifesting as an acute respiratory illness with pneumonia, but can affect multiple organs such as kidney, heart, digestive tract, blood and nervous system. In previous reports of SARS and MERS-CoV infections, acute kidney injury was described in 5 to 15% of patients and was associated with a high mortality rate (60-90%). Recent reports showed renal abnormalities in COVID-9 infected patients. A recent Chinese study also reported that acute kidney injury was an independent risk factor for mortality. However, the exact mechanism of kidney involvement remains unclear: sepsis-related cytokine storm or direct cellular injury from the virus. Also, kidney involvement has not yet been well characterized: heavy albuminuria, hematuria or interstitial nephropathy alone.

A recent study identified viral RNA in kidney tissue and another study succeeded isolating SARS-CoV-2 from the urine sample of an infected patient. These data suggest that the kidney might be a target of this novel coronarivus.

The sponsor suggests characterizing kidney involvement in SARS-CoV-2 infection.

Study objectives are:

  • To give an accurate characterization of kidney involvement in COVID-19
  • To investigate the physiopathologic mechanism of kidney involvement in SARS-CoV-2 infection
  • To identify risk factors for kidney involvement in in SARS-CoV-2 infection
  • To evaluate the impact of kidney involvement in in SARS-CoV-2 infection
  • To assess the long-term health effect of kidney injury on survivors of in SARS-CoV-2 infection

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed COVID-19 disease
  • Age > 18 years-old

排除标准

  • Age < 18 years-old
  • Pregnancy
  • Patient with tutor- or curatorship or in prison
  • Patients who had undergone renal replacement therapy (RRT) before admission

结局指标

主要结局

Kidney involvement in COVID-19 disease

时间窗: until 3 months after discharge or death

Rate of kidney involvement in COVID-19 disease characterized by clinical and biological data

次要结局

  • To evaluate the impact of kidney involvement in SARS-CoV-2 infection(until 3 months after discharge or death)
  • Physiopathologic mechanism of kidney involvement in SARS-CoV-2 infection(until 3 months after discharge or death)
  • To identify risk factors for kidney involvement in in SARS-CoV-2 infection(until 3 months after discharge or death)
  • To assess the long-term health effect of kidney injury on survivors of SARS-CoV-2 infection in case of AKI KDIGO 2 or 3(until 3 months after discharge)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Kidney Involvement in COVID-19 Disease (COVKID) | 临床试验